查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1672068

全球精準醫療市場研究報告 - 產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global Precision Medicine Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 130 Pages | 商品交期: 最快1-2個工作天內

價格

全球精準醫療市場規模預計將從 2024 年的 794.5 億美元成長到 2033 年的 3,296.9 億美元，在 2026 年至 2033 年的預測期內，年複合成長率(CAGR) 將達到 17.13%。

精準醫療市場正在快速成長，這得益於基因組學、生物技術和資料分析方面的進步，可以為個別患者提供個人化的治療方案。隨著醫療保健轉向個人化護理，對精準醫療解決方案的需求正在增加，特別是在腫瘤學領域，標靶療法正在徹底改變癌症治療。基因檢測和生物標記識別的整合使醫療保健提供者能夠制定客製化的治療計劃，以最佳化治療效果並最大限度地減少副作用。由於患者和服務提供者都在尋求更有效、更個人化的醫療保健解決方案，預計這一趨勢將推動市場向前發展。

科技和資料管理的創新也在塑造精準醫療市場的未來。人工智慧和機器學習的興起增強了分析複雜資料集的能力，從而改善了患者分層和治療結果。此外，生物資訊學的進步促進了基因組資料與臨床實踐的整合，使醫療保健提供者能夠根據患者獨特的基因特徵做出明智的決定。隨著這些技術的不斷發展，市場可能見證精準醫療應用在各個治療領域的多樣化，包括罕見疾病和慢性病。

此外，隨著製藥公司和醫療保健組織認知到個人化治療的潛力，精準醫療市場將受益於研發投資的增加。學術機構、產業利害關係人和監管機構之間的合作努力對於推動臨床試驗和確保精準醫療策略的成功實施至關重要。隨著情勢的發展，重點將轉向將精準醫療整合到標準護理途徑中，強調多學科方法在提供最佳患者治療結果方面的重要性。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

報告涵蓋的細分

依技術分類

  • 生物資訊學
  • 巨量資料分析
  • 藥物研發
  • 基因定序
  • 伴隨診斷
  • 其他

按應用

  • 中樞神經系統
  • 免疫學
  • 腫瘤學
  • 呼吸系統
  • 其他

按最終用途

  • 診斷公司
  • 製藥公司
  • 醫療保健 IT 公司
  • 其他

透過定序技術

  • 合成定序
  • 離子半導體定序
  • 連接定序
  • 焦磷酸定序
  • 單分子即時定序
  • 鏈終止定序
  • 奈米孔定序

按產品

  • 耗材
  • 儀器
  • 服務

依給藥途徑

  • 口服
  • 注射劑

透過藥物

  • 艾樂替尼
  • 奧希替尼
  • 美泊利單抗
  • 月桂醯阿立哌唑
  • 其他
  • 公司簡介
  • Biocrates 生命科學
  • Tepnel 製藥服務
  • 諾華
  • Qigen
  • Quest 診斷公司
  • 美納里尼矽生物系統公司
  • 奈米串科技
  • 鷹基因公司
  • 輝瑞
  • 原子學
  • 羅氏
  • 梯瓦製藥
  • 以上清單可以自訂。

目錄

第 1 章：前言

  • 報告描述
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究流程
    • 市場研究方法

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第3章：精準醫療產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 依技術進行市場吸引力分析
    • 市場吸引力分析：按應用
    • 按最終用途進行的市場吸引力分析
    • 透過定序技術進行市場吸引力分析
    • 按產品進行市場吸引力分析
    • 按給藥途徑進行的市場吸引力分析
    • 藥品市場吸引力分析
    • 市場吸引力分析：按地區

第4章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球精準醫療市場分析：按技術

  • 技術概覽
  • 按技術進行的歷史和預測數據分析
  • 生物資訊學
  • 巨量資料分析
  • 藥物研發
  • 基因定序
  • 伴隨診斷
  • 其他

第 6 章：全球精準醫療市場分析：按應用

  • 概述：按應用
  • 歷史和預測數據分析：按應用
  • 中樞神經系統
  • 免疫學
  • 腫瘤學
  • 呼吸系統
  • 其他

第 7 章：全球精準醫療市場分析：依最終用途

  • 按最終用途概述
  • 按最終用途進行的歷史和預測數據分析
  • 診斷公司
  • 製藥公司
  • 醫療保健 IT 公司
  • 其他

第 8 章：全球精準醫療市場分析：依定序技術

  • 定序技術概覽
  • 透過定序技術進行歷史和預測數據分析
  • 合成定序
  • 離子半導體定序
  • 連接定序
  • 焦磷酸定序
  • 單分子即時定序
  • 鏈終止定序
  • 奈米孔定序

第 9 章：全球精準醫療市場分析：按產品

  • 產品概覽
  • 按產品進行的歷史和預測數據分析
  • 耗材
  • 儀器
  • 服務

第 10 章：全球精準醫療市場分析：依給藥途徑

  • 依給藥途徑概述
  • 按給藥途徑進行的歷史和預測數據分析
  • 口服
  • 注射劑

第 11 章：全球精準醫療市場分析：按藥物

  • 藥物概覽
  • 按藥物進行的歷史和預測數據分析
  • 艾樂替尼
  • 奧希替尼
  • 美泊利單抗
  • 月桂醯阿立哌唑
  • 其他

第 12 章：全球精準醫療市場分析：按地區分類

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美各細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲各細分市場銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東和非洲分部銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第 13 章：精準醫療公司的競爭格局

  • 精準醫療市場競爭格局
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品發布
  • 其他進展

第 14 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Biocrates Life Sciences
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Tepnel Pharma Services
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Novartis
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Qiagen
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Quest Diagnostics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Menarini Silicon Biosystems
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • NanoString Technologies
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Eagle Genomics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Pfizer
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Intomics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Roche
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Teva Pharmaceutical
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

Product Code: VMR11214898

Global Precision Medicine Market size is anticipated to grow from USD 79.45 Billion in 2024 to USD 329.69 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 17.13% during the forecast period of 2026 to 2033.

The precision medicine market is experiencing rapid growth, driven by advancements in genomics, biotechnology, and data analytics that enable tailored treatment approaches for individual patients. As healthcare shifts towards personalized care, the demand for precision medicine solutions is increasing, particularly in oncology, where targeted therapies are revolutionizing cancer treatment. The integration of genetic testing and biomarker identification is allowing healthcare providers to develop customized treatment plans that optimize therapeutic efficacy and minimize adverse effects. This trend is expected to propel the market forward, as patients and providers alike seek more effective and individualized healthcare solutions.

Innovations in technology and data management are also shaping the future of the precision medicine market. The rise of artificial intelligence and machine learning is enhancing the ability to analyze complex datasets, leading to improved patient stratification and treatment outcomes. Additionally, advancements in bioinformatics are facilitating the integration of genomic data into clinical practice, enabling healthcare providers to make informed decisions based on a patient's unique genetic profile. As these technologies continue to evolve, the market is likely to witness a diversification of precision medicine applications across various therapeutic areas, including rare diseases and chronic conditions.

Moreover, the precision medicine market will benefit from increased investment in research and development, as pharmaceutical companies and healthcare organizations recognize the potential of personalized therapies. Collaborative efforts between academic institutions, industry stakeholders, and regulatory bodies will be crucial in advancing clinical trials and ensuring the successful implementation of precision medicine strategies. As the landscape evolves, the focus will shift towards integrating precision medicine into standard care pathways, emphasizing the importance of multidisciplinary approaches in delivering optimal patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Technology

  • Bioinformatics
  • Big Data Analytics
  • Drug Discovery
  • Gene Sequencing
  • Companion Diagnostics
  • Others

By Application

  • CNS
  • Immunology
  • Oncology
  • Respiratory
  • Others

By End-Use

  • Diagnostic Companies
  • Pharmaceutical Companies
  • Healthcare IT companies
  • Others

By Sequencing Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Pyrosequencing
  • Single Molecule Real Time Sequencing
  • Chain Termination Sequencing
  • Nanopore Sequencing

By Product

  • Consumables
  • Instruments
  • Services

By Route of Administration

  • Oral
  • Injectable

By Drugs

  • Alectinib
  • Osimertinib
  • Mepolizumab
  • Aripiprazole Lauroxil
  • Others
  • COMPANIES PROFILED
  • Biocrates Life Sciences
  • Tepnel Pharma Services
  • Novartis
  • Qiagen
  • Quest Diagnostics
  • Menarini Silicon Biosystems
  • NanoString Technologies
  • Eagle Genomics
  • Pfizer
  • Intomics
  • Roche
  • Teva Pharmaceutical
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PRECISION MEDICINE INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-Use
    • 3.7.4 Market Attractiveness Analysis By Sequencing Technology
    • 3.7.5 Market Attractiveness Analysis By Product
    • 3.7.6 Market Attractiveness Analysis By Route of Administration
    • 3.7.7 Market Attractiveness Analysis By Drugs
    • 3.7.8 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY TECHNOLOGY

  • 5.1. Overview By Technology
  • 5.2. Historical and Forecast Data Analysis By Technology
  • 5.3. Bioinformatics Historic and Forecast Sales By Regions
  • 5.4. Big Data Analytics Historic and Forecast Sales By Regions
  • 5.5. Drug Discovery Historic and Forecast Sales By Regions
  • 5.6. Gene Sequencing Historic and Forecast Sales By Regions
  • 5.7. Companion Diagnostics Historic and Forecast Sales By Regions
  • 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. CNS Historic and Forecast Sales By Regions
  • 6.4. Immunology Historic and Forecast Sales By Regions
  • 6.5. Oncology Historic and Forecast Sales By Regions
  • 6.6. Respiratory Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-Use
  • 7.2. Historical and Forecast Data Analysis By End-Use
  • 7.3. Diagnostic Companies Historic and Forecast Sales By Regions
  • 7.4. Pharmaceutical Companies Historic and Forecast Sales By Regions
  • 7.5. Healthcare IT companies Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY SEQUENCING TECHNOLOGY

  • 8.1. Overview By Sequencing Technology
  • 8.2. Historical and Forecast Data Analysis By Sequencing Technology
  • 8.3. Sequencing by Synthesis Historic and Forecast Sales By Regions
  • 8.4. Ion Semiconductor Sequencing Historic and Forecast Sales By Regions
  • 8.5. Sequencing by Ligation Historic and Forecast Sales By Regions
  • 8.6. Pyrosequencing Historic and Forecast Sales By Regions
  • 8.7. Single Molecule Real Time Sequencing Historic and Forecast Sales By Regions
  • 8.8. Chain Termination Sequencing Historic and Forecast Sales By Regions
  • 8.9. Nanopore Sequencing Historic and Forecast Sales By Regions

9. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY PRODUCT

  • 9.1. Overview By Product
  • 9.2. Historical and Forecast Data Analysis By Product
  • 9.3. Consumables Historic and Forecast Sales By Regions
  • 9.4. Instruments Historic and Forecast Sales By Regions
  • 9.5. Services Historic and Forecast Sales By Regions

10. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 10.1. Overview By Route of Administration
  • 10.2. Historical and Forecast Data Analysis By Route of Administration
  • 10.3. Oral Historic and Forecast Sales By Regions
  • 10.4. Injectable Historic and Forecast Sales By Regions

11. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY DRUGS

  • 11.1. Overview By Drugs
  • 11.2. Historical and Forecast Data Analysis By Drugs
  • 11.3. Alectinib Historic and Forecast Sales By Regions
  • 11.4. Osimertinib Historic and Forecast Sales By Regions
  • 11.5. Mepolizumab Historic and Forecast Sales By Regions
  • 11.6. Aripiprazole Lauroxil Historic and Forecast Sales By Regions
  • 11.7. Others Historic and Forecast Sales By Regions

12. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY GEOGRAPHY

  • 12.1. Regional Outlook
  • 12.2. Introduction
  • 12.3. North America Sales Analysis
    • 12.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.3.2 North America By Segment Sales Analysis
    • 12.3.3 North America By Country Sales Analysis
    • 12.3.4 United States Sales Analysis
    • 12.3.5 Canada Sales Analysis
    • 12.3.6 Mexico Sales Analysis
  • 12.4. Europe Sales Analysis
    • 12.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.4.2 Europe By Segment Sales Analysis
    • 12.4.3 Europe By Country Sales Analysis
    • 12.4.4 United Kingdom Sales Analysis
    • 12.4.5 France Sales Analysis
    • 12.4.6 Germany Sales Analysis
    • 12.4.7 Italy Sales Analysis
    • 12.4.8 Russia Sales Analysis
    • 12.4.9 Rest Of Europe Sales Analysis
  • 12.5. Asia Pacific Sales Analysis
    • 12.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.5.2 Asia Pacific By Segment Sales Analysis
    • 12.5.3 Asia Pacific By Country Sales Analysis
    • 12.5.4 China Sales Analysis
    • 12.5.5 India Sales Analysis
    • 12.5.6 Japan Sales Analysis
    • 12.5.7 South Korea Sales Analysis
    • 12.5.8 Australia Sales Analysis
    • 12.5.9 South East Asia Sales Analysis
    • 12.5.10 Rest Of Asia Pacific Sales Analysis
  • 12.6. Latin America Sales Analysis
    • 12.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.6.2 Latin America By Segment Sales Analysis
    • 12.6.3 Latin America By Country Sales Analysis
    • 12.6.4 Brazil Sales Analysis
    • 12.6.5 Argentina Sales Analysis
    • 12.6.6 Peru Sales Analysis
    • 12.6.7 Chile Sales Analysis
    • 12.6.8 Rest of Latin America Sales Analysis
  • 12.7. Middle East & Africa Sales Analysis
    • 12.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.7.2 Middle East & Africa By Segment Sales Analysis
    • 12.7.3 Middle East & Africa By Country Sales Analysis
    • 12.7.4 Saudi Arabia Sales Analysis
    • 12.7.5 UAE Sales Analysis
    • 12.7.6 Israel Sales Analysis
    • 12.7.7 South Africa Sales Analysis
    • 12.7.8 Rest Of Middle East And Africa Sales Analysis

13. COMPETITIVE LANDSCAPE OF THE PRECISION MEDICINE COMPANIES

  • 13.1. Precision Medicine Market Competition
  • 13.2. Partnership/Collaboration/Agreement
  • 13.3. Merger And Acquisitions
  • 13.4. New Product Launch
  • 13.5. Other Developments

14. COMPANY PROFILES OF PRECISION MEDICINE INDUSTRY

  • 14.1. Top Companies Market Share Analysis
  • 14.2. Market Concentration Rate
  • 14.3. Biocrates Life Sciences
    • 14.3.1 Company Overview
    • 14.3.2 Company Revenue
    • 14.3.3 Products
    • 14.3.4 Recent Developments
  • 14.4. Tepnel Pharma Services
    • 14.4.1 Company Overview
    • 14.4.2 Company Revenue
    • 14.4.3 Products
    • 14.4.4 Recent Developments
  • 14.5. Novartis
    • 14.5.1 Company Overview
    • 14.5.2 Company Revenue
    • 14.5.3 Products
    • 14.5.4 Recent Developments
  • 14.6. Qiagen
    • 14.6.1 Company Overview
    • 14.6.2 Company Revenue
    • 14.6.3 Products
    • 14.6.4 Recent Developments
  • 14.7. Quest Diagnostics
    • 14.7.1 Company Overview
    • 14.7.2 Company Revenue
    • 14.7.3 Products
    • 14.7.4 Recent Developments
  • 14.8. Menarini Silicon Biosystems
    • 14.8.1 Company Overview
    • 14.8.2 Company Revenue
    • 14.8.3 Products
    • 14.8.4 Recent Developments
  • 14.9. NanoString Technologies
    • 14.9.1 Company Overview
    • 14.9.2 Company Revenue
    • 14.9.3 Products
    • 14.9.4 Recent Developments
  • 14.10. Eagle Genomics
    • 14.10.1 Company Overview
    • 14.10.2 Company Revenue
    • 14.10.3 Products
    • 14.10.4 Recent Developments
  • 14.11. Pfizer
    • 14.11.1 Company Overview
    • 14.11.2 Company Revenue
    • 14.11.3 Products
    • 14.11.4 Recent Developments
  • 14.12. Intomics
    • 14.12.1 Company Overview
    • 14.12.2 Company Revenue
    • 14.12.3 Products
    • 14.12.4 Recent Developments
  • 14.13. Roche
    • 14.13.1 Company Overview
    • 14.13.2 Company Revenue
    • 14.13.3 Products
    • 14.13.4 Recent Developments
  • 14.14. Teva Pharmaceutical
    • 14.14.1 Company Overview
    • 14.14.2 Company Revenue
    • 14.14.3 Products
    • 14.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Technology (USD MN)
  • Bioinformatics Market Sales By Geography (USD MN)
  • Big Data Analytics Market Sales By Geography (USD MN)
  • Drug Discovery Market Sales By Geography (USD MN)
  • Gene Sequencing Market Sales By Geography (USD MN)
  • Companion Diagnostics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • CNS Market Sales By Geography (USD MN)
  • Immunology Market Sales By Geography (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Respiratory Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Diagnostic Companies Market Sales By Geography (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Healthcare IT companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Sequencing Technology (USD MN)
  • Sequencing by Synthesis Market Sales By Geography (USD MN)
  • Ion Semiconductor Sequencing Market Sales By Geography (USD MN)
  • Sequencing by Ligation Market Sales By Geography (USD MN)
  • Pyrosequencing Market Sales By Geography (USD MN)
  • Single Molecule Real Time Sequencing Market Sales By Geography (USD MN)
  • Chain Termination Sequencing Market Sales By Geography (USD MN)
  • Nanopore Sequencing Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Consumables Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectable Market Sales By Geography (USD MN)
  • Analysis By Drugs (USD MN)
  • Alectinib Market Sales By Geography (USD MN)
  • Osimertinib Market Sales By Geography (USD MN)
  • Mepolizumab Market Sales By Geography (USD MN)
  • Aripiprazole Lauroxil Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Precision Medicine Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Precision Medicine Report
  • Market Research Process
  • Market Research Methodology
  • Global Precision Medicine Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Sequencing Technology
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Drugs
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Technology (USD MN)
  • Bioinformatics Market Sales By Geography (USD MN)
  • Big Data Analytics Market Sales By Geography (USD MN)
  • Drug Discovery Market Sales By Geography (USD MN)
  • Gene Sequencing Market Sales By Geography (USD MN)
  • Companion Diagnostics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • CNS Market Sales By Geography (USD MN)
  • Immunology Market Sales By Geography (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Respiratory Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Diagnostic Companies Market Sales By Geography (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Healthcare IT companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Sequencing Technology (USD MN)
  • Sequencing by Synthesis Market Sales By Geography (USD MN)
  • Ion Semiconductor Sequencing Market Sales By Geography (USD MN)
  • Sequencing by Ligation Market Sales By Geography (USD MN)
  • Pyrosequencing Market Sales By Geography (USD MN)
  • Single Molecule Real Time Sequencing Market Sales By Geography (USD MN)
  • Chain Termination Sequencing Market Sales By Geography (USD MN)
  • Nanopore Sequencing Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Consumables Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectable Market Sales By Geography (USD MN)
  • Global Market Analysis By Drugs (USD MN)
  • Alectinib Market Sales By Geography (USD MN)
  • Osimertinib Market Sales By Geography (USD MN)
  • Mepolizumab Market Sales By Geography (USD MN)
  • Aripiprazole Lauroxil Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.